Skip to content

Clinical trials

Phase 3 Oropharyngeal Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Oropharyngeal Neoplasms Phase: Phase 3 Country / region: United States Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20061
20111
20131
20161
20171
20191
20221
20232
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting3
Recruiting3
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center2
National Cancer Institute (NCI)2
Canadian Cancer Trials Group1
Corbus Pharmaceuticals Inc.1
Covenant Health Cancer Center1
ECOG-ACRIN Cancer Research Group1
Henry Ford Health System1
Mayo Clinic1
NRG Oncology1
Radiation Therapy Oncology Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Oropharyngeal Neoplasms13
Mouth Neoplasms6
Head and Neck Neoplasms4
Hypopharyngeal Neoplasms4
Laryngeal Neoplasms4
Squamous Cell Carcinoma of Head and Neck3
Carcinoma2
Nasopharyngeal Neoplasms2
Radiation Injuries2
Esophageal Neoplasms1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.